232 related articles for article (PubMed ID: 18852138)
21. Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts.
Parrill AL; Baker DL
Expert Opin Ther Pat; 2010 Dec; 20(12):1619-25. PubMed ID: 21047298
[TBL] [Abstract][Full Text] [Related]
22. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
[TBL] [Abstract][Full Text] [Related]
24. Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells.
Ptaszynska MM; Pendrak ML; Bandle RW; Stracke ML; Roberts DD
Mol Cancer Res; 2008 Mar; 6(3):352-63. PubMed ID: 18337445
[TBL] [Abstract][Full Text] [Related]
25. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
[TBL] [Abstract][Full Text] [Related]
26. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
[TBL] [Abstract][Full Text] [Related]
27. Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion.
Hoelzinger DB; Nakada M; Demuth T; Rosensteel T; Reavie LB; Berens ME
J Neurooncol; 2008 Feb; 86(3):297-309. PubMed ID: 17928955
[TBL] [Abstract][Full Text] [Related]
28. A rhodium(III)-based inhibitor of autotaxin with antiproliferative activity.
Kang TS; Wang W; Zhong HJ; Liang JX; Ko CN; Lu JJ; Chen XP; Ma DL; Leung CH
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):256-263. PubMed ID: 27888146
[TBL] [Abstract][Full Text] [Related]
29. Development of an activity-based probe for autotaxin.
Cavalli S; Houben AJ; Albers HM; van Tilburg EW; de Ru A; Aoki J; van Veelen P; Moolenaar WH; Ovaa H
Chembiochem; 2010 Nov; 11(16):2311-7. PubMed ID: 20941725
[TBL] [Abstract][Full Text] [Related]
30. Autotaxin and lipid signaling pathways as anticancer targets.
Braddock DT
Curr Opin Investig Drugs; 2010 Jun; 11(6):629-37. PubMed ID: 20496257
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin.
Lee HY; Clair T; Mulvaney PT; Woodhouse EC; Aznavoorian S; Liotta LA; Stracke ML
J Biol Chem; 1996 Oct; 271(40):24408-12. PubMed ID: 8798697
[TBL] [Abstract][Full Text] [Related]
32. Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo.
Zhang H; Xu X; Gajewiak J; Tsukahara R; Fujiwara Y; Liu J; Fells JI; Perygin D; Parrill AL; Tigyi G; Prestwich GD
Cancer Res; 2009 Jul; 69(13):5441-9. PubMed ID: 19509223
[TBL] [Abstract][Full Text] [Related]
33. Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.
Altman MK; Gopal V; Jia W; Yu S; Hall H; Mills GB; McGinnis AC; Bartlett MG; Jiang G; Madan D; Prestwich GD; Xu Y; Davies MA; Murph MM
Mol Cancer; 2010 Jun; 9():140. PubMed ID: 20529378
[TBL] [Abstract][Full Text] [Related]
34. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.
van Meeteren LA; Brinkmann V; Saulnier-Blache JS; Lynch KR; Moolenaar WH
Cancer Lett; 2008 Aug; 266(2):203-8. PubMed ID: 18378389
[TBL] [Abstract][Full Text] [Related]
35. Autotaxin--an LPA producing enzyme with diverse functions.
Nakanaga K; Hama K; Aoki J
J Biochem; 2010 Jul; 148(1):13-24. PubMed ID: 20495010
[TBL] [Abstract][Full Text] [Related]
36. Autotaxin promotes motility via G protein-coupled phosphoinositide 3-kinase gamma in human melanoma cells.
Lee HY; Bae GU; Jung ID; Lee JS; Kim YK; Noh SH; Stracke ML; Park CG; Lee HW; Han JW
FEBS Lett; 2002 Mar; 515(1-3):137-40. PubMed ID: 11943209
[TBL] [Abstract][Full Text] [Related]
37. Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma.
Kawagoe H; Stracke ML; Nakamura H; Sano K
Cancer Res; 1997 Jun; 57(12):2516-21. PubMed ID: 9192834
[TBL] [Abstract][Full Text] [Related]
38. ATX-LPA axis induces expression of OPN in hepatic cancer cell SMMC7721.
Zhang R; Zhang Z; Pan X; Huang X; Huang Z; Zhang G
Anat Rec (Hoboken); 2011 Mar; 294(3):406-11. PubMed ID: 21337710
[TBL] [Abstract][Full Text] [Related]
39. Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD).
Mori K; Kitayama J; Aoki J; Kishi Y; Shida D; Yamashita H; Arai H; Nagawa H
Virchows Arch; 2007 Jul; 451(1):47-56. PubMed ID: 17554559
[TBL] [Abstract][Full Text] [Related]
40. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia.
Khurana S; Tomar A; George SP; Wang Y; Siddiqui MR; Guo H; Tigyi G; Mathew S
Exp Cell Res; 2008 Feb; 314(3):530-42. PubMed ID: 18054784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]